Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-26T03:42:43.321Z Has data issue: false hasContentIssue false

P-178 - Corticosteroids and Behaviour Changes - a Case Report

Published online by Cambridge University Press:  15 April 2020

S. Gomes
Affiliation:
Hospital Magalhaes Lemos, Porto, Portugal
I. Aguiar
Affiliation:
Centro Hospitalar do Porto, Porto, Portugal
V. Henriques
Affiliation:
Hospital Magalhaes Lemos, Porto, Portugal
H. Silva
Affiliation:
Hospital Magalhaes Lemos, Porto, Portugal

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Corticosteroids have been widely prescribed in routine clinical practice and physicians have long known their many side effects. These include metabolic syndrome, osteoporosis, glaucoma, cataracts, peptic ulcers and psychiatric symptoms. Psychiatric side effects from corticosteroids include mania, depression and mood disturbances.

Objectives

Description of a 75 year old female patient's case study, without previous psychiatric history, diagnosed with bronchopneumonia and requiring treatment with prednisone 40 mg daily. Since the first week of treatment she reported behaviour changes such as episodes of elevated and irritable mood, pressured speech, insomnia, jealousy and megalomania delusions. These symptoms worsened, leading to admission in a psychiatric hospital.

Methods

Revision of the scientific literature through Pubmed, using search terms including corticosteroids, mania, depression, psychosis and mood. The research was complemented with information from Uptodate.

Results

Prednisone was suspended and the patient began treatment with Olanzapine, starting with a dosage of 5 mg daily at night, reaching a maximum of 10 mg. The patient recovered complete euthymic mood and reverted to normal functioning. These results support the theory that this psychopathologic state was induced by the corticotherapy administered previously.

Conclusions

Corticosteroids are usually associated with psychiatric disorders and cognitive symptoms. Mania symptoms are the most important manifestations of corticosteroids-induced psychiatric toxicity. It usually occurs within the first two weeks of therapy and it seems to be dose-related. Clinicians should be aware of these facts and carefully monitor patients for psychiatric and cognitive side effects of corticosteroid use.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.